Trial
NCT04616924
RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
RedHill Biopharma Limited
Collaborators
—
Condition
Pulmonary Mycobacterium Avium Complex Infection
Intervention
RHB-204
Why stopped
extremely slow enrollment into study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-18